The ITHS KL2 Multidisciplinary Clinical Research Career Development Program provides the time, funding, mentorship, and training necessary to foster the early career development of clinical and translational researchers. The program is funded by the NIH and welcomes scholars from all health professions.
KL2 Scholars are appointed for up to three years of support. The program encourages all types of clinical research, including patient-oriented research, translational research, small- and large-scale clinical investigation and trials, epidemiologic and natural history studies, health services research, and health behavior research.
Available now!
Meet the Scholars.
Don't hesitate to contact us.
"The people I have met have been phenomenal."
About her research
"Hands down, the KL2 program has been the single most important part of my academic career."
About her research
"The ITHS KL2 program has played a huge part in my work because of the research tools it makes available and the time it allows to focus on my research."
About his research Researcher Spotlight
"What I really like is that we have so much support for our work. Not only our work, but also how we develop our ideas and how we develop as faculty members."
About her research
Finding enough time to dedicate to research pursuits can be a challenge for any junior faculty member. After fulfilling teaching and clinical responsibilities, free periods of time left for research are often few and far between. To mitigate this challenge, the Institute of Translational Health Sciences is supporting three promising investigators through the KL2 Multidisciplinary Clinical Research Career Development Program....
06 February, 2018
Sasha Stanton, MD, PhD, Assistant Professor and ITHS KL2 Scholar has been selected as the recipient of the Athena Endowed Award for Excellence in Breast Cancer Research for her work with cancer vaccines. ...
25 January, 2018
ITHS KL2 Scholar Jonathan Kocarnik, PhD, is focused on identifying genetic and environmental factors associated with cancer risk and survival, particularly for colorectal cancer. ...
06 February, 2017
The Institute is supported by grants UL1 TR002319, KL2 TR002317, and TL1 TR002318 from the NIH National Center for Advancing Translational Sciences through the Clinical and Translational Science Awards Program (CTSA).
Please help us continue to support your research by citing our grant number(s) in publications we supported.